Drug Makers Should Audit Compliance Of Ingredient Suppliers – Sen. Kennedy
Executive Summary
A requirement for pharmaceutical firms to exert tighter control over their ingredient suppliers could be in the offing as Congress contemplates new drug and food safety legislation
You may also be interested in...
Drug Manufacturer Supply Options Could Be Constricted By Legislation
A more compact supply chain for pharmaceutical companies could result from congressional efforts to legislate greater emphasis on drug quality - both by FDA and by industry
Drug Manufacturer Supply Options Could Be Constricted By Legislation
A more compact supply chain for pharmaceutical companies could result from congressional efforts to legislate greater emphasis on drug quality - both by FDA and by industry
Kennedy/Grassley Imports Criminal Liability To Global Drug Safety Efforts
A senior drug company officer or director would be required personally to certify the veracity of product applications and safety submissions to FDA, under Sens. Edward Kennedy, D-Mass., and Chuck Grassley's, R-Iowa, bill to improve safety in global drug manufacturing and distribution